* Immuno-oncology World Congress 2022 (updated 2024-12-03) ~ youtor.org

Immuno-oncology World Congress 2022 (updated 2024-12-03)

Antibodydrug conjugates ADCs in NSCLC [upl. by Bo5]

Antibodydrug conjugates ADCs in NSCLC

Duration: 1:33
461 views | 10 Aug 2022

Combination immunotherapy strategies in colorectal cancer [upl. by Nolrak525]

Combination immunotherapy strategies in colorectal cancer

Duration: 0:23
181 views | 4 months ago

Highlights from COMy [upl. by Shaddock]

Highlights from COMy

Duration: 1:18
291 views | 7 Jun 2022

The emerging role of checkpoint inhibitors in liver cancer [upl. by Acissj]

The emerging role of checkpoint inhibitors in liver cancer

Duration: 1:19
57 views | 5 months ago

Enhancing antitumor immunity through gut microbiota modulation [upl. by Anirret226]

Enhancing antitumor immunity through gut microbiota modulation

Duration: 0:52
16 views | 2 months ago

Challenges associated with implementing immune checkpoint blockade in SCLC [upl. by Onilegna414]

Challenges associated with implementing immune checkpoint blockade in SCLC

Duration: 0:51
52 views | 8 Aug 2022

A trial investigating IberVd in transplantineligible newly diagnosed multiple myeloma [upl. by Jefferey]

A trial investigating IberVd in transplantineligible newly diagnosed multiple myeloma

Duration: 1:10
2 views | 1 month ago

Future developments in cervical cancer treatment [upl. by Andie609]

Future developments in cervical cancer treatment

Duration: 1:03
466 views | 2 Nov 2022

Intracranial CD1cCD141 myeloid dendritic cells with ipilimumab amp nivolumab in highgrade glioma [upl. by Vahe448]

Intracranial CD1cCD141 myeloid dendritic cells with ipilimumab amp nivolumab in highgrade glioma

Duration: 2:48
93 views | 2 months ago

Managing side effects in prolonged treatment with trastuzumab deruxtecan [upl. by Ahsemat37]

Managing side effects in prolonged treatment with trastuzumab deruxtecan

Duration: 0:38
1 views | 1 month ago

Promising future for cholangiocarcinoma diagnosis and treatment [upl. by Ahsiuqal]

Promising future for cholangiocarcinoma diagnosis and treatment

Duration: 2:11
418 views | 7 Jul 2022

Sequencing immunotherapies in multiple myeloma [upl. by Helmut711]

Sequencing immunotherapies in multiple myeloma

Duration: 1:57
64 views | 5 months ago

Treatments for HER2 esophagogastric cancer [upl. by Asum]

Treatments for HER2 esophagogastric cancer

Duration: 2:15
90 views | 13 Jul 2022

Bispecific antibodies in the treatment pipeline for myeloma in the UK [upl. by January414]

Bispecific antibodies in the treatment pipeline for myeloma in the UK

Duration: 1:31
75 views | 4 months ago

Managing patients with multiple myeloma who have failed CART therapy [upl. by Oicnevuj727]

Managing patients with multiple myeloma who have failed CART therapy

Duration: 1:12
175 views | 2 months ago

Highlights from a CLL session BTKis personalizing care novel regimens amp more [upl. by Aiyt]

Highlights from a CLL session BTKis personalizing care novel regimens amp more

Duration: 3:17
59 views | 1 month ago

The sensitization of immune checkpoint inhibitors with subsequent chemotherapy in RR HL [upl. by Stephannie]

The sensitization of immune checkpoint inhibitors with subsequent chemotherapy in RR HL

Duration: 1:10
69 views | 5 months ago

Rationale of using immunotherapy for advanced leiomyosarcoma [upl. by Yemrots]

Rationale of using immunotherapy for advanced leiomyosarcoma

Duration: 3:30
655 views | 6 Oct 2022

Seven challenges in immunooncology [upl. by Sethrida]

Seven challenges in immunooncology

Duration: 1:05
1.1K views | 29 Jan 2018

Overcoming ontarget offtumor toxicity in AML current challenges and potential solutions [upl. by Enyaz382]

Overcoming ontarget offtumor toxicity in AML current challenges and potential solutions

Duration: 1:45
84 views | 2 months ago

Unmet needs in immunotherapy for hepatocellular carcinoma [upl. by Aramaj]

Unmet needs in immunotherapy for hepatocellular carcinoma

Duration: 1:21
206 views | 5 Jan 2023

Safety and efficacy of inotuzumab ozogamicin conditioning for alloSCT in lymphoid malignancies [upl. by Terpstra]

Safety and efficacy of inotuzumab ozogamicin conditioning for alloSCT in lymphoid malignancies

Duration: 2:45
63 views | 1 month ago

The need for novel agents to treat patients with MCL who have relapsed after targeted therapy [upl. by Nye]

The need for novel agents to treat patients with MCL who have relapsed after targeted therapy

Duration: 2:22
166 views | 1 month ago

The future of antibodydrug conjugates in endometrial cancer [upl. by Mercola50]

The future of antibodydrug conjugates in endometrial cancer

Duration: 1:43
58 views | 1 month ago

5year followup of EV and pembrolizumab for lamUC in the EV103 trial [upl. by Rossen251]

5year followup of EV and pembrolizumab for lamUC in the EV103 trial

Duration: 1:30
53 views | 1 month ago

Enhancing treatment outcomes in RCC and NSCLC with Akkermansia supplements [upl. by Onin]

Enhancing treatment outcomes in RCC and NSCLC with Akkermansia supplements

Duration: 0:59
21 views | 1 month ago

ImmunoOncology Symposium Part 1 [upl. by Dnallor149]

ImmunoOncology Symposium Part 1

Duration: 2:16:45
3.2K views | 15 Nov 2023

Looking forward to EHA 2024 key clinical trials to look out for in the myeloma space [upl. by Elatia]

Looking forward to EHA 2024 key clinical trials to look out for in the myeloma space

Duration: 1:15
299 views | 6 months ago

ESMO ImmunoOncology Congress 2023 Access to all the latest updates in immunooncology [upl. by Mead936]

ESMO ImmunoOncology Congress 2023 Access to all the latest updates in immunooncology

Duration: 1:37
555 views | 25 Jul 2023

AHEADMERIT firstline pembrolizumab and BNT113 in advanced HPV16 HNSCC [upl. by Angelika]

AHEADMERIT firstline pembrolizumab and BNT113 in advanced HPV16 HNSCC

Duration: 3:48
37 views | 2 months ago

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024